| Literature DB >> 30314694 |
Saeko Kimura1, Tomoki Uchida1, Yuki Tokuyama1, Mayumi Hosokawa1, Junya Nakato1, Atsushi Kurabayashi2, Masaru Sato2, Hideyuki Suzuki2, Ryuhei Kanamoto1, Kousaku Ohinata3.
Abstract
Rubisco, an enzyme for photosynthetic carbon dioxide fixation, is a major green leaf protein and known as the most abundant protein on the Earth. We found that Rubisco digested mimicking gastrointestinal enzymatic conditions exhibited anxiolytic-like effects after oral administration in mice. Based on a comprehensive peptide analysis of the digest using nanoLC-Orbitrap-MS and the structure-activity relationship of known anxiolytic-like peptides, we identified SYLPPLTT, SYLPPLT and YHIEPV [termed Rubisco anxiolytic-like peptide (rALP)-1, rALP-1(1-7) and rALP-2, respectively], which exhibited potent anxiolytic-like effects after oral administration. The anxiolytic-like effects of rALP-1/rALP-1(1-7) were blocked by a serotonin 5-HT1A receptor antagonist, whereas rALP-2-induced effects were inhibited by a δ-opioid receptor antagonist. In conclusion, novel Rubisco-derived anxiolytic-like peptides, rALP-1/rALP-1(1-7) and rALP-2, act via independent neural pathways.Entities:
Keywords: Anxiolytic-like effect; Comprehensive analysis; Green leaf; Oral administration; Peptide; Rubisco
Mesh:
Substances:
Year: 2018 PMID: 30314694 DOI: 10.1016/j.bbrc.2018.09.195
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575